Matches in Nanopublications for { ?s ?p "[MKP1 repression is required for the chemosensitizing effects of NF-kappaB and PI3K inhibitors to cisplatin in non-small cell lung cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 14 of
14
with 100 items per page.
- NP360997.RAS8YTYpyf2iI-v8Sj1p5LNw6GGAfjONtMbI8k-5H-YPk130_assertion description "[MKP1 repression is required for the chemosensitizing effects of NF-kappaB and PI3K inhibitors to cisplatin in non-small cell lung cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP360997.RAS8YTYpyf2iI-v8Sj1p5LNw6GGAfjONtMbI8k-5H-YPk130_provenance.
- assertion description "[MKP1 repression is required for the chemosensitizing effects of NF-kappaB and PI3K inhibitors to cisplatin in non-small cell lung cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP415385.RA5nBM5q31eLQU8gbRHo9JREZHLur2dPgfmeddfqpXIy8130_assertion description "[MKP1 repression is required for the chemosensitizing effects of NF-kappaB and PI3K inhibitors to cisplatin in non-small cell lung cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP415385.RA5nBM5q31eLQU8gbRHo9JREZHLur2dPgfmeddfqpXIy8130_provenance.
- NP314358.RA6Cr8prp4Dor9wc6CFdmuqgktyC01zvhoeQDB_Nwg1yc130_assertion description "[MKP1 repression is required for the chemosensitizing effects of NF-kappaB and PI3K inhibitors to cisplatin in non-small cell lung cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP314358.RA6Cr8prp4Dor9wc6CFdmuqgktyC01zvhoeQDB_Nwg1yc130_provenance.
- assertion description "[MKP1 repression is required for the chemosensitizing effects of NF-kappaB and PI3K inhibitors to cisplatin in non-small cell lung cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[MKP1 repression is required for the chemosensitizing effects of NF-kappaB and PI3K inhibitors to cisplatin in non-small cell lung cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[MKP1 repression is required for the chemosensitizing effects of NF-kappaB and PI3K inhibitors to cisplatin in non-small cell lung cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[MKP1 repression is required for the chemosensitizing effects of NF-kappaB and PI3K inhibitors to cisplatin in non-small cell lung cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP747336.RAWUUUC0oxZMqaLPg_EMo5Zyn8ikwzA02XBwIsjaNk4bY130_assertion description "[MKP1 repression is required for the chemosensitizing effects of NF-kappaB and PI3K inhibitors to cisplatin in non-small cell lung cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP747336.RAWUUUC0oxZMqaLPg_EMo5Zyn8ikwzA02XBwIsjaNk4bY130_provenance.
- NP747332.RAj7FMXJAe4PLJk_pkwlbLfjjvgUJt0HG-gW9s7t25EJ8130_assertion description "[MKP1 repression is required for the chemosensitizing effects of NF-kappaB and PI3K inhibitors to cisplatin in non-small cell lung cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP747332.RAj7FMXJAe4PLJk_pkwlbLfjjvgUJt0HG-gW9s7t25EJ8130_provenance.
- NP747337.RAuUGERJwHaTwUa8fdN6ZYeiHAkQRbU1KSM64tgfpoKCs130_assertion description "[MKP1 repression is required for the chemosensitizing effects of NF-kappaB and PI3K inhibitors to cisplatin in non-small cell lung cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP747337.RAuUGERJwHaTwUa8fdN6ZYeiHAkQRbU1KSM64tgfpoKCs130_provenance.
- NP362223.RA5vXBcpzC8MTdY4O92iOllijR3ABic-cA9Qa-9Dd9HUk130_assertion description "[MKP1 repression is required for the chemosensitizing effects of NF-kappaB and PI3K inhibitors to cisplatin in non-small cell lung cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP362223.RA5vXBcpzC8MTdY4O92iOllijR3ABic-cA9Qa-9Dd9HUk130_provenance.
- NP747333.RAGg3NYJzScEAYCfjzbuw9U4tlotERIAGOZ7e9X9yzTDk130_assertion description "[MKP1 repression is required for the chemosensitizing effects of NF-kappaB and PI3K inhibitors to cisplatin in non-small cell lung cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP747333.RAGg3NYJzScEAYCfjzbuw9U4tlotERIAGOZ7e9X9yzTDk130_provenance.
- NP747334.RA_2hOJiJXFy2c0axlWC0vSFguiNy-Bm1GH7lZm1WpZGs130_assertion description "[MKP1 repression is required for the chemosensitizing effects of NF-kappaB and PI3K inhibitors to cisplatin in non-small cell lung cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP747334.RA_2hOJiJXFy2c0axlWC0vSFguiNy-Bm1GH7lZm1WpZGs130_provenance.